Tissue Regenix Group (TRX) Stock Chart & Stock Price History GBX 36.44 -1.56 (-4.11%) As of 11:43 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsBuy This Stock Tissue Regenix Group Stock Price Performance The Tissue Regenix Group (TRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 45.73%, with a year-to-date return of -39.27%. In the past month, the stock has increased 15.87%, reflecting recent market activity. As of the latest close, Tissue Regenix Group traded at GBX 39.52 with a market cap of £35.63 million and volume of 92,445 shares. Receive TRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tissue Regenix Group and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+27.86%1 Month Performance+15.87%3 Month Performance+7.18%Year-To-Date Performance-39.27%1 Year Performance-45.73% TRX Stock Chart for Friday, July, 25, 2025 TRX Chart by TradingView Tissue Regenix Group Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2025GBX 39.52GBX 36.44-7.79%GBX 40GBX 3617,737 shs£32.85 million07/24/2025GBX 37.75GBX 39.52+4.69%GBX 40.96GBX 36.9792,445 shs£35.63 million07/23/2025GBX 37GBX 37.75+2.03%GBX 41GBX 36281,428 shs£34.04 million07/22/2025GBX 33GBX 37+12.12%GBX 37GBX 32200,025 shs£33.36 million07/21/2025GBX 28.50GBX 33+15.79%GBX 33GBX 30.66285,885 shs£29.75 million07/18/2025GBX 25GBX 28.50+14.00%GBX 30GBX 25261,021 shs£25.69 million07/17/2025GBX 26.60GBX 25-6.02%GBX 27GBX 2542,146 shs£22.54 million07/16/2025GBX 26.60GBX 26.60GBX 27GBX 2527,723 shs£23.98 million07/15/2025GBX 26.05GBX 26.60+2.11%GBX 27GBX 2527,723 shs£23.98 million07/14/2025GBX 27.60GBX 26.05-5.62%GBX 26.50GBX 26.0513,656 shs£23.49 million Get the Latest News and Ratings for TRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tissue Regenix Group and its competitors with MarketBeat's FREE daily newsletter. 07/11/2025GBX 26.95GBX 27.60+2.41%GBX 27.60GBX 25.20113,157 shs£24.88 million07/10/2025GBX 26.20GBX 26.95+2.86%GBX 26.95GBX 26.5074,964 shs£24.30 million07/09/2025GBX 26.06GBX 26.20+0.54%GBX 26.84GBX 26119,283 shs£23.62 million07/08/2025GBX 26GBX 26.06+0.23%GBX 26.50GBX 26.06108,387 shs£23.49 million07/07/2025GBX 28.50GBX 26-8.77%GBX 29GBX 25209,267 shs£23.44 million07/04/2025GBX 28.60GBX 28.60GBX 29GBX 2860,333 shs£25.78 million07/03/2025GBX 28.70GBX 28.60-0.35%GBX 29GBX 2860,333 shs£25.78 million07/02/2025GBX 29.50GBX 28.70-2.71%GBX 30GBX 28103,102 shs£25.88 million07/01/2025GBX 29.05GBX 29.50+1.55%GBX 29.59GBX 29.5014,802 shs£26.60 million06/30/2025GBX 29.95GBX 29.05-3.01%GBX 29.92GBX 2935,969 shs£26.19 million06/27/2025GBX 29.05GBX 29.95+3.10%GBX 30GBX 291.24 million shs£27.00 million06/26/2025GBX 31.45GBX 29.05-7.63%GBX 31.27GBX 2951,597 shs£26.19 million06/25/2025GBX 30.45GBX 31.45+3.28%GBX 31.70GBX 30.2064,176 shs£28.35 million06/24/2025GBX 30.85GBX 30.45-1.30%GBX 31GBX 28.6585,351 shs£27.45 million Related Companies NG Stock Chart WPM Stock Chart IAG Stock Chart SFR Stock Chart HVO Stock Chart SBTX Stock Chart FUM Stock Chart SAR Stock Chart AREC Stock Chart POLB Stock Chart Receive TRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tissue Regenix Group and its competitors with MarketBeat's FREE daily newsletter. This page (LON:TRX) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tissue Regenix Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Tissue Regenix Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
